AGEN
Price
$6.04
Change
-$0.03 (-0.49%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
165.6M
NTLA
Price
$12.76
Change
-$1.48 (-10.39%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
1.48B
7 days until earnings call
Interact to see
Advertisement

AGEN vs NTLA

Header iconAGEN vs NTLA Comparison
Open Charts AGEN vs NTLABanner chart's image
Agenus
Price$6.04
Change-$0.03 (-0.49%)
Volume$2.61K
Capitalization165.6M
Intellia Therapeutics
Price$12.76
Change-$1.48 (-10.39%)
Volume$108.19K
Capitalization1.48B
AGEN vs NTLA Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.5B. The market cap for tickers in the group ranges from 58 to 309.36B. NONOF holds the highest valuation in this group at 309.36B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 6%. For the same Industry, the average monthly price growth was 18%, and the average quarterly price growth was 29%. AAVXF experienced the highest price growth at 794%, while REPL experienced the biggest fall at -74%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 106%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -3 (-100 ... +100)

Market Cap

The average market capitalization across the group is 820.72M. The market cap for tickers in the group ranges from 166.42M to 1.48B. NTLA holds the highest valuation in this group at 1.48B. The lowest valued company is AGEN at 166.42M.

High and low price notable news

The average weekly price growth across all stocks in the group was 7%. For the same group, the average monthly price growth was 40%, and the average quarterly price growth was 50%. NTLA experienced the highest price growth at 19%, while AGEN experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the group was 46%. For the same stocks of the group, the average monthly volume growth was 30% and the average quarterly volume growth was 154%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 98
Price Growth Rating: 37
SMR Rating: 98
Profit Risk Rating: 100
Seasonality Score: -25 (-100 ... +100)
VS
AGEN vs. NTLA commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a StrongBuy and NTLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (AGEN: $6.07 vs. NTLA: $14.24)
Brand notoriety: AGEN and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 48% vs. NTLA: 127%
Market capitalization -- AGEN: $165.6M vs. NTLA: $1.48B
AGEN [@Biotechnology] is valued at $165.6M. NTLA’s [@Biotechnology] market capitalization is $1.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 3 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • NTLA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both AGEN and NTLA are a bad buy in the short-term.

Price Growth

AGEN (@Biotechnology) experienced а -4.56% price change this week, while NTLA (@Biotechnology) price change was +19.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.88%. For the same industry, the average monthly price growth was +18.15%, and the average quarterly price growth was +28.82%.

Reported Earning Dates

AGEN is expected to report earnings on May 12, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+5.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.48B) has a higher market cap than AGEN($166M). AGEN YTD gains are higher at: 121.533 vs. NTLA (22.127). AGEN has higher annual earnings (EBITDA): -81.06M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. AGEN (18.5M). AGEN has less debt than NTLA: AGEN (92M) vs NTLA (119M). AGEN has higher revenues than NTLA: AGEN (99.5M) vs NTLA (45.6M).
AGENNTLAAGEN / NTLA
Capitalization166M1.48B11%
EBITDA-81.06M-530.8M15%
Gain YTD121.53322.127549%
P/E Ratio0.20N/A-
Revenue99.5M45.6M218%
Total Cash18.5M504M4%
Total Debt92M119M77%
FUNDAMENTALS RATINGS
AGEN vs NTLA: Fundamental Ratings
AGEN
NTLA
OUTLOOK RATING
1..100
1120
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for AGEN (96). This means that NTLA’s stock grew somewhat faster than AGEN’s over the last 12 months.

NTLA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that NTLA’s stock grew similarly to AGEN’s over the last 12 months.

NTLA's SMR Rating (97) in the Biotechnology industry is in the same range as AGEN (100). This means that NTLA’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (36) in the Biotechnology industry is in the same range as NTLA (38). This means that AGEN’s stock grew similarly to NTLA’s over the last 12 months.

AGEN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as NTLA (100). This means that AGEN’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENNTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 25 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTSFY27.560.75
+2.81%
Mitsui Fudosan Co., Ltd.
RLFTF2.840.02
+0.53%
RELIEF THERAPEUTICS HLDG AG
AUSDF0.90N/A
N/A
Perenti Global Ltd.
BWPC0.05N/A
N/A
Blue Water Petroleum Corp.
JUMSF27.50N/A
N/A
Jumbo SA

AGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-0.82%
TAOX - AGEN
91%
Closely correlated
+6.62%
ALLR - AGEN
87%
Closely correlated
+13.60%
NRXP - AGEN
83%
Closely correlated
+1.34%
PALI - AGEN
81%
Closely correlated
+41.86%
AXON - AGEN
42%
Loosely correlated
-2.15%
More

NTLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+5.56%
VCYT - NTLA
69%
Closely correlated
+2.98%
CRSP - NTLA
67%
Closely correlated
+3.35%
BEAM - NTLA
65%
Loosely correlated
+2.88%
RXRX - NTLA
57%
Loosely correlated
-1.68%
ABCL - NTLA
56%
Loosely correlated
+1.42%
More